Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...

Shares in the Irvine-based medical device company rose 29% to $23.64 and a $975 million market within the first three hours ...

“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, ...

President Donald Trump’s early action on health care reversed some of his predecessor’s policies, but former President Joe ...

DURHAM, N.C.and SEATTLE, Jan. 28, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...

Beta Bionics, Inc. (BBNX) is planning to raise $112 million in an initial public offering on Thursday, January 30th, IPO Scoop reports. The company will be issuing 7,500,000 shares at $14.00-$16.00 ...

Today, Plantsulin blends this century-old discovery with modern scientific validation to offer a fast, convenient“whole-body reboot” for maintaining optimal glucose levels. Unlike restrictive diets or ...

BECKLEY, W.Va. — Jury deliberations begin Wednesday morning in the murder trial of former Raleigh County pharmacist Natalie ...

SLOWLY lifting her head off her sweat-drenched pillow, Aisleyne Horgan-Wallace vomits into the sick bucket next to her bed. ...

The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...